Anzeige
Mehr »
Login
Donnerstag, 30.03.2023 Börsentäglich über 12.000 News von 687 internationalen Medien
Rasierklingenscharfe News! Wird NuGen Medical Devices zum Pionier der Branche?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Endpoints News

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiJ&J halts huge study of experimental RSV vaccine and kills program in surprise decision
MiNo longer 'dead or just hibernating,' drugmakers return to heart medicines
MiAstraZeneca axes license agreement with Aridis, placing Europe-funded PhIII on hold
MiEuropean investment group closes €260M raise for dementia fund
MiFDA lifts partial hold on Blueprint's CDK2 inhibitor
DiVanda wins court case against FDA over disclosure of CRL details for sleep drug
DiOhio attorney general sues several PBMs over antitrust concerns
DiHouse committee chair requests info from FDA on funding for trials involving 'viral manipulation'
DiPharma ad total tops $8B again in 2022, led by top brands from Sanofi and Regeneron, AbbVie
DiFDA plans upcoming adcomms for OTC contraceptive, epinephrine nasal spray, Intarcia's last shot
DiHouse committee to investigate FDA's response to ongoing drug shortages
DiMarketingRx roundup: AbbVie drives endometriosis awareness; Novartis adds to Cosentyx campaign
DiQ&A: Pfizer corporate communications chief Sally Susman discusses book crafted in pandemic and personal lessons
DiFerring closes key research site, letting go 89 workers in San Diego
DiBiomea Fusion stock soars on early-stage diabetes data
DiTiny multiomics biotech secures former J&J drug, new execs and new financing
DiIntra-Cellular Therapies gets a boost on PhIII depression drug data
DiEvotec's CNS deal with Bristol Myers gets $50M infusion and eight-year extension
DiViking soars on early-stage weight loss data as it maps out PhII
DiNovartis rides with Bicycle for new pact on targeted radiotherapies
DiWith Boehringer Ingelheim's help, Roivant churns out another Vant to go up against Endeavor, Impact founders
DiGunning for 2023 approval, GSK details PhIII data for Jemperli in frontline endometrial cancer
DiAbbVie drops CytomX partnership, leaving PhII program in the air
DiJeffrey Bluestone brings his startup haul to $400M+, joining forces with Regeneron on cell therapies
DiApplied Molecular Transport prepares to close up shop as it pauses R&D, replaces CEO, lays off 57%